Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
IOrganBio Raises $2M Seed Round Led by First Star Ventures
SeedVenture Capital

IOrganBio Raises $2M Seed Round Led by First Star Ventures

•October 30, 2025
•Oct 30, 2025
0

Participants

iOrganBio

iOrganBio

company

Cape Fear BioCapital

Cape Fear BioCapital

investor

Alix Ventures

Alix Ventures

investor

First Star

First Star

investor

2ndF

2ndF

investor

IndieBio

IndieBio

investor

Terasaki Institute

Terasaki Institute

investor

Why It Matters

The infusion of capital accelerates iOrganBio’s ability to supply high‑quality human cells, a critical bottleneck in biotech R&D, and signals broader market confidence in cell‑based manufacturing as a growth engine for the drug‑development ecosystem.

Deal Summary

Chapel Hill-based human cell production startup iOrganBio raised $2M in a funding round led by First Star Ventures with participation from IndieBio, Cape Fear BioCapital, 2ndF, Terasaki Institute, and Alix Ventures. The company, founded in 2024, will use the capital to advance its cell production technologies.

0

Comments

Want to join the conversation?

Loading comments...